UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2017

 

Commission File Number 333-209744

 

TODOS MEDICAL LTD.

(Translation of registrant's name into English)

 

 

1 Hamada Street

Rehovot, Israel

+972-8-633-3964

 

 (Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

x Form 20-F      ¨ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

 

 

 

 

 

 

 

  

Resignation of Chief Financial Officer

 

On October 15, 2017, Mr. Shlomo Zakai, CPA informed Todos Medical Ltd. (the “Company”) of his intention to resign as the Company’s Chief Financial Officer. The resignation will take effect on December 15, 2017. The Company appreciates Mr. Zakai’s service and contributions to the Company and wishes him the best of luck in his future endeavors.

  

 

  

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TODOS MEDICAL LTD.  
       
  By: /s/ Rami Zigdon  
    Name: Rami Zigdon   
    Title:   Chief Executive Officer  
       
Date: October 23, 2017